2/2 © Reuters. FILE PHOTO: GlaxoSmithKline Pharmaceutical Company Logo Seen at Stevenage Facility 2/2
(Reuters) – GSK beat analysts’ expectations for first-quarter earnings as more people visited clinics for routine vaccines after COVID-19 limits were lowered, adding on Wednesday that plans to split into two they were “on the right track” and details are expected in June.
Disclaimer: Fusion Media
wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media
assumes no responsibility for any business
losses you may incur as a result of the use of this data. Fusion Media or anyone involved with Fusion Media will not accept any responsibility for loss or damage as a result of reliance on information, including data, quotes, charts, and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading
the financial markets, it is one of the riskiest forms of investment possible.